189 related articles for article (PubMed ID: 16181457)
1. Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.
Boehncke WH; Ochsendorf FR; Noll S; Urban M; Popp A; Waldherr D; Haunschild J; Litzenburger T
Br J Dermatol; 2005 Oct; 153(4):758-66. PubMed ID: 16181457
[TBL] [Abstract][Full Text] [Related]
2. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
3. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
[TBL] [Abstract][Full Text] [Related]
4. 7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immunodeficient mouse transplant model.
Bhagavathula N; Nerusu KC; Hanosh A; Aslam MN; Sundberg TB; Opipari AW; Johnson K; Kang S; Glick GD; Varani J
J Pharmacol Exp Ther; 2008 Mar; 324(3):938-47. PubMed ID: 18055879
[TBL] [Abstract][Full Text] [Related]
5. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
Coleman EJ; Brooks KJ; Smallshaw JE; Vitetta ES
J Immunother; 2006; 29(5):489-98. PubMed ID: 16971805
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.
Huang YW; Richardson JA; Vitetta ES
Cancer Res; 1995 Feb; 55(3):610-6. PubMed ID: 7834632
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
Wang YD; Hu Y; Zhang L; Huang J; Sun CY
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):659-63. PubMed ID: 18399169
[TBL] [Abstract][Full Text] [Related]
8. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.
Sapra P; Stein R; Pickett J; Qu Z; Govindan SV; Cardillo TM; Hansen HJ; Horak ID; Griffiths GL; Goldenberg DM
Clin Cancer Res; 2005 Jul; 11(14):5257-64. PubMed ID: 16033844
[TBL] [Abstract][Full Text] [Related]
10. The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis.
Torres-Alvarez B; Castanedo-Cazares JP; Fuentes-Ahumada C; Moncada B
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):334-9. PubMed ID: 17309454
[TBL] [Abstract][Full Text] [Related]
11. Influence of PUVA and UVB radiation on expression of ICAM-1 and VCAM-1 molecules in psoriasis vulgaris.
Cabrijan L; Lipozencić J; Batinac T; Lenković M; Stanić Zgombić Z
Coll Antropol; 2008 Oct; 32 Suppl 2():53-6. PubMed ID: 19138007
[TBL] [Abstract][Full Text] [Related]
12. Pan-selectin antagonism improves psoriasis manifestation in mice and man.
Friedrich M; Bock D; Philipp S; Ludwig N; Sabat R; Wolk K; Schroeter-Maas S; Aydt E; Kang S; Dam TN; Zahlten R; Sterry W; Wolff G
Arch Dermatol Res; 2006 Feb; 297(8):345-51. PubMed ID: 16362415
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of postlaminectomy epidural fibrosis with monoclonal antibodies against intercellular adhesion molecule-1 and CD-18.
Sabuncuoğlu H; Bavbek M; Sabuncuoğlu B; Gadelha E; Köse K; Preul M
Spine J; 2007; 7(4):459-65. PubMed ID: 17630144
[TBL] [Abstract][Full Text] [Related]
14. Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes.
Albanesi C; De Pità O; Girolomoni G
Clin Dermatol; 2007; 25(6):581-8. PubMed ID: 18021896
[TBL] [Abstract][Full Text] [Related]
15. Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab.
Bissonnette R; Langley RG; Papp K; Matheson R; Toth D; Hultquist M; Geba GP; White B
Arch Dermatol Res; 2009 Jul; 301(6):429-42. PubMed ID: 19471949
[TBL] [Abstract][Full Text] [Related]
16. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC
Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
[TBL] [Abstract][Full Text] [Related]
18. A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
Caspary F; Elliott G; Navé BT; Verzaal P; Rohrbach M; Das PK; Nagelkerken L; Nieland JD
Br J Dermatol; 2005 Nov; 153(5):937-44. PubMed ID: 16225603
[TBL] [Abstract][Full Text] [Related]
19. Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice.
Bhagavathula N; Nerusu KC; Fisher GJ; Liu G; Thakur AB; Gemmell L; Kumar S; Xu ZH; Hinton P; Tsurushita N; Landolfi NF; Voorhees JJ; Varani J
Am J Pathol; 2005 Apr; 166(4):1009-16. PubMed ID: 15793282
[TBL] [Abstract][Full Text] [Related]
20. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
